BRPI0414049A - compostos e composições como inibidores de proteìna cinase - Google Patents

compostos e composições como inibidores de proteìna cinase

Info

Publication number
BRPI0414049A
BRPI0414049A BRPI0414049-4A BRPI0414049A BRPI0414049A BR PI0414049 A BRPI0414049 A BR PI0414049A BR PI0414049 A BRPI0414049 A BR PI0414049A BR PI0414049 A BRPI0414049 A BR PI0414049A
Authority
BR
Brazil
Prior art keywords
compounds
compositions
protein kinase
kinase inhibitors
sapk2
Prior art date
Application number
BRPI0414049-4A
Other languages
English (en)
Inventor
Qiang Ding
Nathanael Schiander Gray
Bing Li
Yi Liu
Tetsuo Uno
Original Assignee
Irm Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irm Llc filed Critical Irm Llc
Publication of BRPI0414049A publication Critical patent/BRPI0414049A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"COMPOSTOS E COMPOSIçõES COMO INIBIDORES DE PROTEìNA CINASE". A presente invenção fornece uma nova classe de compostos, composições farmacêuticas compreendendo tais compostos e métodos de emprego de tais compostos para tratar ou prevenir doenças ou distúrbios associados com atividade de cinase anormal ou desregulada, particularmente doenças ou distúrbios que envolvem a ativação anormal das Abl, BCRAbl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, SAPK2<244> e SAPK2<225> cinases.
BRPI0414049-4A 2003-08-28 2004-08-27 compostos e composições como inibidores de proteìna cinase BRPI0414049A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49853203P 2003-08-28 2003-08-28
PCT/US2004/027997 WO2005039486A2 (en) 2003-08-28 2004-08-27 Compounds and compositions as protein kinase inhibitors

Publications (1)

Publication Number Publication Date
BRPI0414049A true BRPI0414049A (pt) 2006-10-24

Family

ID=34519982

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414049-4A BRPI0414049A (pt) 2003-08-28 2004-08-27 compostos e composições como inibidores de proteìna cinase

Country Status (9)

Country Link
US (2) US7338957B2 (pt)
EP (1) EP1658290A4 (pt)
JP (1) JP2007504159A (pt)
CN (1) CN100439365C (pt)
AU (1) AU2004283093B2 (pt)
BR (1) BRPI0414049A (pt)
CA (1) CA2536535A1 (pt)
MX (1) MXPA06002347A (pt)
WO (1) WO2005039486A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0202873D0 (en) * 2002-02-07 2002-03-27 Novartis Ag Organic compounds
TW200616974A (en) * 2004-07-01 2006-06-01 Astrazeneca Ab Chemical compounds
ATE492545T1 (de) * 2005-05-13 2011-01-15 Irm Llc Verbindungen und zusammensetzungen als proteinkinase-hemmer
GB0615327D0 (en) 2006-03-30 2006-09-13 Univ Edinburgh Culture medium containing kinase inhibitors and uses thereof
CA2645170A1 (en) * 2006-03-30 2007-10-11 The University Court Of The University Of Edinburgh Culture medium containing kinase inhibitors, and uses thereof
PT2007391E (pt) 2006-04-07 2013-03-11 Novartis Ag Combinação compreendendo: a) um composto de pirimidil-aminobenzamida e b) um inibidor da cinase thr315ile
WO2008147831A1 (en) * 2007-05-23 2008-12-04 Smithkline Beecham Corporation Anthranilamides
CN101868461B (zh) 2007-08-02 2013-09-25 米伦纽姆医药公司 合成e1活化酶抑制剂的方法
US7981903B2 (en) * 2007-08-08 2011-07-19 Glaxosmithkline Llc 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer
CN104311563B (zh) * 2007-11-28 2016-12-07 达那-法伯癌症研究所 Bcr-abl的小分子豆蔻酸酯抑制剂及其使用方法
CN101918079A (zh) * 2008-01-22 2010-12-15 默克专利有限公司 蛋白激酶抑制剂及其用途
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
HUE035029T2 (en) 2008-05-21 2018-03-28 Ariad Pharma Inc Kinase inhibitor phosphorus derivatives
CN104016987A (zh) 2009-05-14 2014-09-03 米伦纽姆医药公司 氨基磺酸((1s,2s,4r)-4-{4-[(1s)-2,3-二氢-1h-茚-1-基氨基]-7h-吡咯并[2,3-d]嘧啶-7-基}-2-羟基环戊基)甲酯盐酸盐
US8728763B2 (en) 2009-08-11 2014-05-20 Response Genetics Methods, primers, probes and kits useful for the detection of BRAF mutations
EA201391626A1 (ru) 2011-05-04 2014-03-31 Ариад Фармасьютикалз, Инк. Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака
US20150166591A1 (en) 2012-05-05 2015-06-18 Ariad Pharmaceuticals, Inc. Methods and compositions for raf kinase mediated diseases
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
CN104876879B (zh) * 2015-04-14 2018-05-18 中国科学院合肥物质科学研究院 一种bcr-abl激酶抑制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2203642T3 (es) * 1995-06-07 2004-04-16 Pfizer Inc. Derivados de pirimidina heterociclicos con anillos condensados.
NZ510588A (en) * 1998-09-18 2003-08-29 Abbott Gmbh & Co Pyrrolopyrimidines as protein kinase inhibitors
ES2245955T3 (es) * 1999-12-21 2006-02-01 Sugen, Inc. 7-aza-indolin-2-onas 4-sustituidas y su utilizacion como inhibidores de proteina-quinasa.
UA76977C2 (en) * 2001-03-02 2006-10-16 Icos Corp Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
US20040235867A1 (en) * 2001-07-24 2004-11-25 Bilodeau Mark T. Tyrosine kinase inhibitors

Also Published As

Publication number Publication date
JP2007504159A (ja) 2007-03-01
US20050159391A1 (en) 2005-07-21
AU2004283093B2 (en) 2009-02-26
US20080108616A1 (en) 2008-05-08
AU2004283093A1 (en) 2005-05-06
US7338957B2 (en) 2008-03-04
EP1658290A4 (en) 2009-04-15
MXPA06002347A (es) 2006-05-19
WO2005039486A2 (en) 2005-05-06
CN100439365C (zh) 2008-12-03
CA2536535A1 (en) 2005-05-06
CN1842529A (zh) 2006-10-04
WO2005039486A3 (en) 2006-03-16
EP1658290A2 (en) 2006-05-24

Similar Documents

Publication Publication Date Title
BRPI0607307A2 (pt) compostos e composições como inibidores de proteìna cinase
BRPI0511978A (pt) compostos e composições como inibidores de proteìnas quinases
BRPI0414049A (pt) compostos e composições como inibidores de proteìna cinase
BRPI0512422A (pt) compostos e composições como inobidores da proteìna quinase
BRPI0413563A (pt) compostos e composições como inibidores de atividade do receptor de quìnase de tirosina
BRPI0415210A (pt) compostos e composições como inibidores de proteìna cinase
BRPI0507668A (pt) compostos e composições como inibidores de proteìna cinase
DE602006014540D1 (en) Pyrrolopyridinderivate als proteinkinaseinhibitoren
BRPI0414930A (pt) compostos e composições como inibidores de proteìnas cinases
MX2008001969A (es) Compuestos y composiciones como inhibidores de proteina cinasa.
MX2008001605A (es) Compuestos y composiciones de tiazol-2-il amino 5-substituido como inhibidores de cinasa proteica.
BRPI0413005A (pt) compostos e composições como inibidores da proteìna cinase
WO2006124731A3 (en) Compounds and compositions as protein kinase inhibitors
TNSN07176A1 (en) Compounds and compositions as protein kinase inhibitors
NO20092612L (no) Forbindelser og metode for kinasemodulering og indikasjoner for dette
UA98629C2 (ru) Соединения и способ модуляции киназ
MX2009003649A (es) Inhibidores de cinasa de proteina y metodos para utilizarlos.
BRPI0719797A8 (pt) Compostos e composições como inibidores de proteína cinase
BR0215429A (pt) Composto de fórmula i e seus usos, métodos de inibição da atividade e método de inibição da ativação de um receptor de monoamina, métodos de tratamento, método de identificação de polimorfismo genético e método de identificação de paciente
MA30340B1 (fr) Nouveaux composes
MXPA05010711A (es) Compuestos y composiciones novedosos como inhibidores de proteina-quinasa.
WO2006101783A3 (en) Compounds and compositions as protein kinase inhibitors
BRPI0509172A (pt) pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento
EA200970447A1 (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
BRPI0511527A (pt) compostos e composições como moduladores de ppar

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. C07D 471/04, 487/04; A61K 31/519, 31/4355; A61P 35/00

Ipc: C07D 471/04 (2011.01), C07D 487/04 (2011.01), A61K

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.